IM Cannabis (IMCC) Non Operating Interest Expenses (2020 - 2024)

IM Cannabis' Non Operating Interest Expenses history runs 5 years deep, the most recent figure standing at -$361409.1 for Q1 2024.

• On a quarterly basis, Non Operating Interest Expenses rose 38.54% year-over-year to -$361409.1 in Q1 2024; TTM through Mar 2024 was -$4.2 million, a 27.48% decrease from a year earlier, with the FY2019 full-year figure at $986023.1, changed N/A from the prior year.
• Non Operating Interest Expenses advanced to -$361409.1 in Q1 2024 per IMCC's latest filing, from -$1.6 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $890002.5 in Q3 2020 and bottomed at -$5.1 million in Q2 2020.
• The 5-year median for Non Operating Interest Expenses is -$441745.2 (2021), against an average of -$958399.4.
• Across the five-year window, Non Operating Interest Expenses soared 91.35% in 2021 and tumbled 339.59% in 2022, its largest moves.
• Year by year, Non Operating Interest Expenses stood at $890002.5 in 2020, then tumbled by 96.34% to $32570.8 in 2021, then tumbled by 5390.62% to -$1.7 million in 2022, then climbed by 8.67% to -$1.6 million in 2023, then surged by 77.04% to -$361409.1 in 2024.
• Per Business Quant, the three latest IMCC Non Operating Interest Expenses figures stand at -$361409.1 (Q1 2024), -$1.6 million (Q2 2023), and -$588058.6 (Q1 2023).